Japan Direct-to-Consumer Laboratory Testing Market

Japan Direct-to-Consumer Laboratory Testing Market Outlook 2031

• The Japan direct-to-consumer laboratory testing market was valued at US$ 190.84 Mn in 2020
• It is estimated to expand at a CAGR of 26.1% from 2021 to 2031
• The Japan direct-to-consumer laboratory testing market is expected to cross the value of US$ 2.4 Bn by the end of 2031

Analysts’ Viewpoint on Japan Direct-to-Consumer Laboratory Testing Market Scenario

With the COVID-19 pandemic triggering interest in telehealth and consumer-initiated testing, companies in the Japan direct-to-consumer laboratory testing market are aiming to expand their DTC operations. DTC genetic testing aimed at guiding a patient’s diet or exercise remains largely unproven in producing better outcomes. Hence, market stakeholders should implement laboratory stewardship programs that improve patient-centered care. Moreover, genetic counseling sessions are being conducted to explain details and options at appropriate education levels. Mobile apps are being developed to facilitate patient retrieval of results. Healthcare providers in the Japan direct-to-consumer laboratory testing market are increasing patient access to their electronic medical records. Furthermore, educational materials are being written in patient’s language of choice. Enhanced communication between patients and physicians through text, phone, and electronic medical record is helping to improve the patient quality of life.

Patient-specific Laboratory Stewardship Programs Improving Clinical Numbers

Telehealth is making it possible for increasing the availability of direct-to-consumer (DTC) laboratory testing. Patient-centered laboratory stewardship is acting as a key driver for growth of the Japan direct-to-consumer laboratory testing market. There is a rising need for patient care that is respectful of and responsive to individual patient preferences, values, and needs. These trends are helping in ensuring that patient values guide all clinical decisions.

The concept of patient centered capitalism is storming the Japan direct-to-consumer laboratory testing market. Stakeholders are prioritizing the interests of patients over those of financial and other stakeholders within both the healthcare system & its suppliers. Patient-centered laboratory stewardship is proving beneficial to improve important areas of lab testing and DTC testing such as test ordering, result retrieval, result interpretation, and financial fairness for patients & other stakeholders.

Request a sample to get extensive insights into the Direct-to-Consumer Laboratory Testing Market

Users Prefer Convenience of COVID-19 Home Test Collection Kits

The sudden rise in coronavirus cases in India, China, and the U.K. has once again put healthcare companies in Japan under great scrutiny. Since the U.S. Food and Drug Administration (FDA) has authorized the use of COVID-19 home test collection kits, companies in the Japan direct-to-consumer laboratory testing market are taking cues from the same. Manufacturers are developing COVID-19 test home collection kits that can be used by individuals of 18 years & above without the need for a prescription.

Companies in the Japan direct-to-consumer laboratory testing market are innovating in COVID-19 test home collection kits that enable positive or invalid results that are delivered to the user by phone call from a healthcare provider or lab. Such kits are allowing users to self-collect a nasal swab sample at home and then send that sample for testing to labs.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Can DTC Testing Become Industry Norm in Future?

Risks and benefits of DTC tests are influencing the growth of the Japan market of COVID-19 home test collection kits. Convenience, low cost, and confidentiality advantages are bolstering the market growth, whereas difficult to interpret results & risk of incorrect self-diagnosis are creating concerns among individuals. Nevertheless, advantages such as non-health tests and increase in the number of people becoming health conscious tend to offset the disadvantages of DTC tests. The popularity of at-home DNA test kits is contributing to the growth of the market for direct-to-consumer laboratory testing.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Direct-to-Consumer Laboratory Testing Market

Disease Prevention with DTC Genetic Testing Benefitting Patients and Healthcare Practitioners

Personalized, precision, and genomic medicine based on DNA sequencing holds potentials to offer opportunities for improving the overall public health. The Japan direct-to-consumer laboratory testing market is undergoing significant changes with DNA sequencing being applied for disease prevention such as heart diseases, cancers, and metabolic diseases.

The identification of patients’ risk profile is becoming necessary in the Japan direct-to-consumer laboratory testing market. DTC genetic testing is giving access to information on their risks of suffering from a wide range of chronic diseases.

AI & Cloud Computing Enabling Development of Tailored Health Management Solutions

The Japan direct-to-consumer laboratory testing market is slated to clock an astonishing CAGR throughout the assessment period. Market stakeholders and telecommunication companies are anticipated to enter into collaborations to help individuals stay informed about their health status by sending lab results directly to their mobile devices.

Smartphone based healthcare services are growing prominent in the market of direct-to-consumer laboratory testing. The combination of artificial intelligence (AI) and cloud computing is being deployed for genetic decoding to provide services like tailored health management. Cloud computing is helping to store and manage personal genome analysis information.

Japan Direct-to-Consumer Laboratory Testing Market: Overview

• Direct-to-consumer laboratory testing, also known as direct access testing, permits consumers to order laboratory tests directly from a laboratory without necessarily having to work with a healthcare provider
• Surge in demand for early disease detection & diagnosis, increase in geriatric population, and rise in emphasis on patient-driven healthcare are projected to drive the direct-to-consumer laboratory testing market in Japan

Japan Direct-to-Consumer Laboratory Testing Market: Key Drivers

• Increase in geriatric population susceptible to chronic illnesses drives the demand for direct-to-consumer laboratory testing. Presently, Japan is facing new problems with its medical insurance and nursing care systems for the elderly due to rapid increase in the geriatric population. DTC laboratory testing is gaining popularity among the geriatric population, which, in turn, propels the market.
• There is a surge in emphasis on patient-driven healthcare, and direct-to-consumer laboratory testing has significantly affected patient care, its cost, and the role of the laboratory professional. Retail outlets such as Walmart, Sam’s Club, and Costco provide one-stop health care services. These services include onsite testing for glucose and cholesterol, as well as tests that are later sent out to reference laboratories.
• Prevalence of various lifestyle-associated and infectious diseases such as obesity, hypertension, diabetes, cancer, and STD has increased. Diet is one of the key risk factors that leads to increase in the number of patients with obesity and high blood pressure. Japan's disease structure has been changing due to the rapid aging of the population and lifestyle changes.

Japan Direct-to-Consumer Laboratory Testing Market: Segmentation

• In terms of sample type, the direct-to-consumer laboratory testing market in Japan has been classified into blood, urine, saliva, and others
• Based on test type, the direct-to-consumer laboratory testing market in Japan has been divided into genetic testing, disease risk assessment testing, CBC, diabetes testing, TSH testing, and others
• Each of the segments has been analyzed in detail for direct-to-consumer laboratory testing trends, recent trends & developments, drivers, restraints, opportunities, and useful insights. The direct-to-consumer laboratory testing market report provides current and future revenue (US$ Mn) for each of these segments for the period from 2017 to 2031, considering 2020 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2021 to 2031 along with market size estimations.

Major Players

• The report concludes with the company profiles section that includes key information about the major players in the direct-to-consumer laboratory testing market in Japan
• Key players in the market include
  • Quest Diagnostics Incorporated
  • WellnessFX
  • Ulta Lab Tests, LLC
  • Walk-In Lab, LLC
  • Genesis Healthcare Co.
  • MyHeritage Ltd.
  • Gene by Gene, Ltd.
  • Full Genomes Corporation, Inc.
  • OME Care
• Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Japan Direct-to-Consumer Laboratory Testing Market Snapshot

Japan Direct-to-Consumer Laboratory Testing Market – Segmentation

TMR’s study on the direct-to-consumer laboratory testing market in Japan includes information divided into three segments: sample type, test type, and region. Changing industry trends and other crucial market dynamics associated with these segments of the direct-to-consumer laboratory testing market in Japan are discussed in detail.